Search Results - Biaggi‐Rudolf, Christine

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    SAKK 19/17: safety analysis of first-line durvalumab in patients with PD-L1 positive, advanced nonsmall cell lung cancer and a performance status of 2

    SAKK 19/17: safety analysis of first-line durvalumab in patients with PD-L1 positive, advanced nonsmall cell lung cancer and a performance status of 2 by Mark, Michael, Froesch, Patrizia, Eboulet, Eric Innocents, Addeo, Alfredo, Pless, Miklos, Rothschild, Sacha I., Janthur, Wolf-Dieter, Burmeister, Henning, Friedlaender, Alex, Schneider, Martina, Metaxas, Yannis, Joerger, Markus, Wannesson, Luciano, Schwitter, Michael, Baudoux, Nathalie, Weindler, Susanne, Biaggi-Rudolf, Christine, Früh, Martin

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Multimodal Treatment in Operable Stage III NSCLC: A Pooled Analysis on Long-Term Results of Three SAKK trials (SAKK 16/96, 16/00, and 16/01)

    Multimodal Treatment in Operable Stage III NSCLC: A Pooled Analysis on Long-Term Results of Three SAKK trials (SAKK 16/96, 16/00, and 16/01) by Früh, Martin, Betticher, Daniel C., Stupp, Roger, Xyrafas, Alexandros, Peters, Solange, Ris, Hans Beat, Mirimanoff, Rene Olivier, Ochsenbein, Adrian F., Schmid, Ralph, Matzinger, Oscar, Stahel, Rolf A., Weder, Walter, Guckenberger, Matthias, Rothschild, Sacha I., Lardinois, Didier, Mach, Nicholas, Mark, Michael, Gautschi, Oliver, Thierstein, Sandra, Biaggi Rudolf, Christine, Pless, Miklos

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Importance and outcome relevance of central pathology review in prostatectomy specimens: data from the SAKK 09/10 randomized trial on prostate cancer

    Importance and outcome relevance of central pathology review in prostatectomy specimens: data from the SAKK 09/10 randomized trial on prostate cancer by Ghadjar, Pirus, Hayoz, Stefanie, Genitsch, Vera, Zwahlen, Daniel R., Hölscher, Tobias, Gut, Philipp, Guckenberger, Matthias, Hildebrandt, Guido, Müller, Arndt‐Christian, Putora, Paul M., Papachristofilou, Alexandros, Stalder, Lukas, Biaggi‐Rudolf, Christine, Sumila, Marcin, Kranzbühler, Helmut, Najafi, Yousef, Ost, Piet, Azinwi, Ngwa C., Reuter, Christiane, Bodis, Stephan, Khanfir, Kaouthar, Budach, Volker, Aebersold, Daniel M., Thalmann, George N.

    Published in BJU international
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Impact of dose intensified salvage radiation therapy on urinary continence recovery after radical prostatectomy: Results of the randomized trial SAKK 09/10

    Impact of dose intensified salvage radiation therapy on urinary continence recovery after radical prostatectomy: Results of the randomized trial SAKK 09/10 by Ghadjar, Pirus, Hayoz, Stefanie, Bernhard, Jürg, Zwahlen, Daniel R., Stein, Jürgen, Hölscher, Tobias, Gut, Philipp, Polat, Bülent, Hildebrandt, Guido, Müller, Arndt-Christian, Putora, Paul Martin, Papachristofilou, Alexandros, Schär, Corinne, Dal Pra, Alan, Biaggi Rudolf, Christine, Wust, Peter, Aebersold, Daniel M., Thalmann, George N.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Prolonged rituximab maintenance in follicular lymphoma patients: long-term results of the SAKK 35/03 randomized trial

    Prolonged rituximab maintenance in follicular lymphoma patients: long-term results of the SAKK 35/03 randomized trial by Moccia, Alden A., Taverna, Christian, Schär, Sämi, Vanazzi, Anna, Rondeau, Stéphanie, Hitz, Felicitas, Mingrone, Walter, Pabst, Thomas, Cevreska, Lidija, del Giglio, Auro, Raats, Johann, Rauch, Daniel, Vorobiof, Daniel A., Lohri, Andreas, Ruegsegger, Céline, Biaggi Rudolf, Christine, Rusterholz, Corinne, Hayoz, Stefanie, Ghielmini, Michele, Zucca, Emanuele

    Published in Blood advances
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Fulvestrant with or without selumetinib, a MEK 1/2 inhibitor, in breast cancer progressing after aromatase inhibitor therapy: A multicentre randomised placebo-controlled double-blind phase II trial, SAKK 21/08

    Fulvestrant with or without selumetinib, a MEK 1/2 inhibitor, in breast cancer progressing after aromatase inhibitor therapy: A multicentre randomised placebo-controlled double-bli... by Zaman, Khalil, Winterhalder, Ralph, Mamot, Christoph, Hasler-Strub, Ursula, Rochlitz, Christoph, Mueller, Andreas, Berset, Catherine, Wiliders, Hans, Perey, Lucien, Rudolf, Christine Biaggi, Hawle, Hanne, Rondeau, Stephanie, Neven, Patrick

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Rituximab Maintenance Treatment For a Maximum Of 5 Years In Follicular Lymphoma: Results Of The Randomized Phase III Trial SAKK 35/03

    Rituximab Maintenance Treatment For a Maximum Of 5 Years In Follicular Lymphoma: Results Of The Randomized Phase III Trial SAKK 35/03 by Taverna, Christian J., Martinelli, Giovanni, Hitz, Felicitas, Mingrone, Walter, Pabst, Thomas, Cevreska, Lidija, del Giglio, Auro, Vanazzi, Anna, Laszlo, Daniele, Raats, Johann, Rauch, Daniel, Vorobiof, Daniel A., Lohri, Andreas, Zucca, Emanuele, Biaggi Rudolf, Christine, Rondeau, Stephanie, Rusterholz, Corinne, Ghielmini, Michele

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: